Conference Learning Objectives:
 
  1. Describe the new UDI requirements that will become effective in 2018.
  2. Detail three ways to better manage data in your organization.
  3. Formulate strategies to facilitate better exchange of data with suppliers.
  4. Outline the Key Attributes of a High Reliability model and how it translates into the medical model. 
  5. Describe the techniques utilized in optimizing the “human factor” with respect to advancing system performance and the significance and results gained by leading transdisciplinary teams. 
  6. Outline best practices for handling product shortages when they impact your organization.
  7. Specify the complex issues that have resulted in a shortage of IV saline bags in the United States.
  8. Demonstrate knowledge of methods of cost cutting that can also improve services.
  9. Identify strategies to implement Value-based Purchasing best practices.
  10. Outline the Phase 3 Meaningful Use Regulations and requirements.
  11. Define ways to create supply chain value as health systems grow and expand.
  12. Identify methods of preparing for possible disruptors and how to mitigate risk.
  13. Describe how to develop strategies for implementing new technological advances in your organization.
  14. Identify three ways that blockchain can improve workflows.
  15. Identify the benefits of supply chain digitization.
  16. Outline the ways that 3D technology can improve outcomes and lower costs.
  17. Describe three potential implications that nanotechnology is having in healthcare today.
  18. Discuss the importance of high quality, reliable data for the success of AI utilization and the inherent concerns regarding the privacy and security of such data.
  19. Categorize the capabilities, applications, and limitations of AI. 
  20. Outline the potential impact AI might have on the future of healthcare.
  21. Develop an understanding of the challenges facing suppliers in the healthcare supply chain.
  22. Describe methods of providing value to healthcare providers and their patients.
  23. Formulate a plan to meet the expectations of providers, regional collaborative, and GPOs. 
  24. Differentiate various value-based payment models and identify opportunities for win/win partnerships between suppliers and IDN’s.
  25. Define the supply chain challenges hospitals and health systems are experiencing today.
  26. Identify ways that suppliers and providers can forge stronger partnerships.
  27. Describe the recent modifications to the 340B drug discount program.
  28. Outline the challenges that 340B presents for hospital pharmacy executives.
  29. Detail methods of driving savings as a result of the 340B program.
  30.  Explain the benefits that biosimilars may provide to patients, payers and providers.
  31. Evaluate clinical practice implications for pharmacists surrounding biosimilar use with a focus on agents used in gastrointestinal and rheumatic diseases.
  32. Recognize core knowledge and skillset needed to prepare pharmacists to incorporate biosimilar use routinely into clinical practice.
  33. Demonstrate how pharmacy can help manage patient populations, especially through medication reconciliation.
  34. Evaluate ways that pharmacists can help reduce costly readmissions.
  35.  Outline how drug price hyperinflation is harming IDNs’ bottom line, and what to do about it.
  36. Identify best practices to effectively manage pharmacy operations across a multi-site health system.
  37. Describe the benefits that implementation of a pharmacy consolidated services center can provide.
  38. Outline the challenges that must be addressed in the supply and regulation of pharmaceutical inventories.
  39. Identify the types of patients who would benefit from the implementation of a medication therapy management plan.
  40. Discuss ways that a medication therapy management plan can optimize a patient’s health.
  41. Outline the core elements of a medication therapy management plan.
  42. Detail the factors causing uncertainty and financial hardship for pharmacy patients.
  43. Identify three assistance programs that can help mitigate these burdens.
  44. Discuss the impact these programs have on patients and providers.
  45. Identify three benchmarking categories and savings that can be realized in these areas.
  46. Discuss the challenges in obtaining reliable benchmark information.
  47. Explain the four primary personality styles based on DiSC.
  48. Identify ways to change your communication style to influence others.
  49.  Examine key issues between suppliers and providers that impact the healthcare supply chain.
  50.   Describe the metrics that encompass an end-to-end view of the pharmacy supply chain.
  51.  Identify strategies for using data and analytics to improve inventory decision-making.
  52. Detail successful partnerships between supply chain and pharmacy organizations.
  53. Explain the effect that shortages and exorbitant costs of generic drugs are having on patients.
  54. Discuss the ways that Project RX will help make essential generic medications more available and more affordable.
  55. Discuss the changes that a not-for-profit drug manufacturing organization could have on the pharmaceutical industry.
  56. Detail the impact that drug shortages are having on pharmacies and the steps the FDA is taking to manage those shortages.
  57. Identify methods to ensure that supplies of high-priority drugs that are deemed essential will not run short nationally if disruptions in manufacturing and distribution occur.
  58. Discuss other strategies to prevent drug shortages in the future.